PER1 and CLOCK: Potential circulating biomarkers for head and neck squamous cell carcinoma

Head and Neck

Volumn 36, Issue 7, 2014, Pages 1018-1026

  Hsu, Cheng Ming ^a,b   Lin, Pai Mei ^c   Lai, Chi Chih ^a   Lin, Hsin Ching ^a   Lin, Sheng Fung ^d,e   Yang, Ming Yu ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

circadian clock genes; CLOCK; head and neck squamous cell carcinoma; PER1; peripheral blood leukocytes

Indexed keywords

PER1 PROTEIN; TRANSCRIPTION FACTOR CLOCK; CIRCADIAN RHYTHM SIGNALING PROTEIN; CLOCK PROTEIN, HUMAN; MESSENGER RNA; PER1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; BUCCAL CANCER; CANCER PATIENT; CANCER PROGNOSIS; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CANCER; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LIP CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH CAVITY; OROPHARYNX CANCER; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE CANCER; CASE CONTROL STUDY; DOWN REGULATION; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CLOCK PROTEINS; DOWN-REGULATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PERIOD CIRCADIAN PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84902547690     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23402     Document Type: Article

References (33)

1. Klein JD, Christopoulos A, Ahn SM, Gooding WE, Grandis JR, Kim S,. Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma. Head Neck 2012; 34: 1269-1276.
2. Mehanna H, Paleri V, West CM, Nutting C,. Head and neck cancer-part 1: epidemiology, presentation, and preservation. Clin Otolaryngol 2011; 36: 65-68.
3. Department of Health Executive Yuan, Taiwan, Republic of China, Taiwan. Cancer Registry Annual Report in Taiwan Area, 2005. 2006.
4. Massano J, Regateiro FS, Januário G, Ferreira A,. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67-76.
5. Gery S, Koeffler HP,. Circadian rhythms and cancer. Cell Cycle 2010; 9: 1097-1103.
6. Rosato E, Kyriacou CP,. Origins of circadian rhythmicity. J Biol Rhythms 2002; 17: 506-511.
7. Young MW, Kay SA,. Time zones: a comparative genetics of circadian clocks. Nat Rev Genet 2001; 2: 702-715.
8. Yu EA, Weaver DR,. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY) 2011; 3: 479-493.
9. Blask DE, Hill SM, Dauchy RT, et al. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 2011; 51: 259-269.
10. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG,. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005; 26: 1241-1246.
11. Stevens RG, Hansen J, Costa G, et al. Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med 2011; 68: 154-162.
12. Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY,. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol 2012; 33: 149-155.
13. Kusanagi H, Hida A, Satoh K, et al. Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells. Neurosci Res 2008; 61: 136-142.
14. Hastings MH, Reddy AB, Maywood ES,. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003; 4: 649-661.
15. Mormont MC, Waterhouse J, Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000; 6: 3038-3045.
16. Lee CC,. Tumor suppression by the mammalian period genes. Cancer Causes Control 2006; 17: 525-530.
17. Spengler ML, Kuropatwinski KK, Comas M, et al. Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription. Proc Natl Acad Sci U S A 2012; 109: E2457-E2465.
18. Lin YM, Chang JH, Yeh KT, et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog 2008; 47: 925-933.
19. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL,. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 2007; 9: 797-800.
20. Yang MY, Chang JG, Lin PM, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 2006; 97: 1298-1307.
21. Shih HC, Choo KB, Chang TJ, et al. Disturbance of circadian gene expression in endometrial cancer: detection by real-time quantitative RT-PCR. Oncol Rep 2005; 14: 1533-1538.
22. Yang MY, Yang WC, Lin PM, et al. Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms 2011; 26: 136-148.
23. Chen YG, Mantalaris A, Bourne P, Keng P, Wu JH,. Expression of mPer1 and mPer2, two mammalian clock genes, in murine bone marrow. Biochem Biophys Res Commun 2000; 276: 724-728.
24. Smaaland R, Sothern RB, Laerum OD, Abrahamsen JF,. Rhythms in human bone marrow and blood cells. Chronobiol Int 2002; 19: 101-127.
25. Boivin DB, James FO, Wu A, Cho-Park PF, Xiong H, Sun ZS,. Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 2003; 102: 4143-4145.
26. Fukuya H, Emoto N, Nonaka H, Yagita K, Okamura H, Yokoyama M,. Circadian expression of clock genes in human peripheral leukocytes. Biochem Biophys Res Commun 2007; 354: 924-928.
27. Guess J, Burch JB, Ogoussan K, et al. Circadian disruption, Per3, and human cytokine secretion. Integr Cancer Ther 2009; 8: 329-336.
28. Lavebratt C, Sjöholm LK, Soronen P, et al. CRY2 is associated with depression. PLoS One 2010; 5: e9407.
29. Cai Y, Liu S, Sothern RB, Xu S, Chan P,. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur J Neurol 2010; 17: 550-554.
30. Stamenkovic JA, Olsson AH, Nagorny CL, et al. Regulation of core clock genes in human islets. Metabolism 2012; 61: 978-985.
31. Ando H, Takamura T, Matsuzawa-Nagata N, et al. Clock gene expression in peripheral leucocytes of patients with type 2 diabetes. Diabetologia 2009; 52: 329-335.
32. Davis S, Mirick DK,. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle. Cancer Causes Control 2006; 17: 539-545.
33. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 95: 825-828.